Effect of pharmacological treatment on outcomes of heart failure with preserved ejection fraction: an updated systematic review and network meta-analysis of randomized controlled trials.

Lin, Yaowang; Cai, Zhigang; Yuan, Jie; Liu, Huadong; Pang, Xinli; Chen, Qiuling; Tang, Xinzheng; Geng, Qingshan; Dong, Shaohong

Lin, Yaowang; Cai, Zhigang; Yuan, Jie; Liu, Huadong; Pang, Xinli; Chen, Qiuling; Tang, Xinzheng; Geng, Qingshan; Dong, Shaohong.

Affiliation

Lin Y; Department of Cardiology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; the First Affiliated Hospital, Southern University of Science and Technology), Cardiovascular Minimally Invasive Medical Engineering Technology Research and Development Center, Shenzhen Key M
Cai Z; Institution of Shenzhen Hospital, Guangzhou University of Chinese Medicine (Futian), Shenzhen, 518000, People's Republic of China.
Yuan J; Department of Cardiology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; the First Affiliated Hospital, Southern University of Science and Technology), Cardiovascular Minimally Invasive Medical Engineering Technology Research and Development Center, Shenzhen Key M
Liu H; Department of Cardiology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; the First Affiliated Hospital, Southern University of Science and Technology), Cardiovascular Minimally Invasive Medical Engineering Technology Research and Development Center, Shenzhen Key M
Pang X; Department of Cardiology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; the First Affiliated Hospital, Southern University of Science and Technology), Cardiovascular Minimally Invasive Medical Engineering Technology Research and Development Center, Shenzhen Key M
Chen Q; Department of Pharmacy, Shenzhen People's Hospital, Shenzhen, People's Republic of China.
Tang X; Institution of Shenzhen Hospital, Guangzhou University of Chinese Medicine (Futian), Shenzhen, 518000, People's Republic of China. xnktangxinzheng@yeah.net.
Geng Q; Department of Cardiology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; the First Affiliated Hospital, Southern University of Science and Technology), Cardiovascular Minimally Invasive Medical Engineering Technology Research and Development Center, Shenzhen Key M
Dong S; Department of Geriatrics, Shenzhen People's Hospital, Shenzhen, People's Republic of China. szgengqingshan@yeah.net.

Cardiovasc Diabetol ; 21(1): 237, 2022 11 08.

Article in En | MEDLINE | ID: mdl-36348348

Subject(s)

Heart Failure; Sodium-Glucose Transporter 2 Inhibitors; Humans; Stroke Volume; Sodium-Glucose Transporter 2 Inhibitors/therapeutic use; Network Meta-Analysis; Randomized Controlled Trials as Topic; Heart Failure/diagnosis; Heart Failure/drug therapy; Heart Failure/chemically induced; Angiotensin-Converting Enzyme Inhibitors/therapeutic use; Death

Key words

All-cause death; Cardiac death; HF hospitalization; Heart failure with preserved ejection fraction; Randomized control trials; Registered in PROSPERO (CRD42021247034); Worsening HF events

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sodium-Glucose Transporter 2 Inhibitors / Heart Failure Type of study: Clinical_trials / Diagnostic_studies / Systematic_reviews Limits: Humans Language: En Journal: Cardiovasc Diabetol Journal subject: ANGIOLOGIA / CARDIOLOGIA / ENDOCRINOLOGIA Year: 2022 Type: Article

Fulltext

XML

PubMed Links

Search on Google